Department of Alzheimer Disease Research, National Center for Geriatrics and Gerontology, 35 Gengo, Morioka, Obu, Aichi 474-8511, Japan.
J Biol Chem. 2010 Dec 3;285(49):38382-8. doi: 10.1074/jbc.M110.146258. Epub 2010 Oct 1.
Apolipoprotein E (apoE) ε4 and hyperhomocysteinemia are risk factors for Alzheimer disease (AD). The dimerization of apoE3 by disulfide bonds between cysteine residues enhances apoE3 function to generate HDL. Because homocysteine (Hcy) harbors a thiol group, we examined whether Hcy interferes with the dimerization of apoE3 and thereby impairs apoE3 function. We found that Hcy inhibits the dimerization of apoE3 and reduces apoE3-mediated HDL generation to a level similar to that by apoE4, whereas Hcy does not affect apoE4 function. Western blot analysis of cerebrospinal fluid showed that the ratio of apoE3 dimers was significantly lower in the samples from the patients with hyperhomocysteinemia than in those that from control subjects. Hyperhomocysteinemia induced by subcutaneous injection of Hcy to apoE3 knock-in mice decreased the level of the apoE3 dimer in the brain homogenate. Because apoE-HDL plays a role in amyloid β-protein clearance, these results suggest that two different risk factors, apoE4 and hyperhomocysteinemia, may share a common mechanism that accelerates the pathogenesis of AD in terms of reduced HDL generation.
载脂蛋白 E (apoE) ε4 和高同型半胱氨酸血症是阿尔茨海默病 (AD) 的危险因素。半胱氨酸残基之间的二硫键使 apoE3 二聚化,增强了 apoE3 的功能,从而产生高密度脂蛋白 (HDL)。由于同型半胱氨酸 (Hcy) 含有巯基,我们研究了 Hcy 是否会干扰 apoE3 的二聚化,从而损害 apoE3 的功能。我们发现 Hcy 抑制 apoE3 的二聚化,并降低 apoE3 介导的 HDL 生成水平,使其与 apoE4 相似,而 Hcy 不影响 apoE4 的功能。对来自高同型半胱氨酸血症患者的脑脊液的 Western blot 分析显示,apoE3 二聚体的比例明显低于对照组。apoE3 敲入小鼠皮下注射 Hcy 诱导的高同型半胱氨酸血症降低了脑匀浆中 apoE3 二聚体的水平。由于 apoE-HDL 在淀粉样β蛋白清除中发挥作用,这些结果表明,两种不同的危险因素 apoE4 和高同型半胱氨酸血症可能具有共同的机制,通过降低 HDL 的生成加速 AD 的发病机制。